首页|舒肝养心扶正法联合正念干预治疗肺癌术后患者抑郁状态的临床效果

舒肝养心扶正法联合正念干预治疗肺癌术后患者抑郁状态的临床效果

扫码查看
目的 探讨舒肝养心扶正法联合正念干预治疗肺癌术后患者抑郁状态的临床疗效。方法 将 64 例上海中医药大学附属龙华医院 2018 年 5 月至 2019年 3 月收治的肺癌术后抑郁状态患者按随机数字表法分为治疗组和对照组,每组32例,对照组给予舒肝养心扶正法中药治疗,治疗组在舒肝养心扶正法中药治疗的基础上联合正念干预,两组疗程均为 3 个月,观察治疗组和对照组患者的临床疗效、中医证候积分、Zung抑郁自评量表(SDS)积分、汉密尔顿抑郁量表(HAMD)积分、肺癌治疗功能评价系统(FACT-L)积分、血清T淋巴细胞亚群(CD3+、CD4+、CD8+)指标的变化情况。结果 治疗组和对照组患者的临床总有效率分别为 93。8%(30/32)和 75。0%(24/32),治疗组明显优于对照组(χ2=13。55,P=0。001)。治疗后,治疗组和对照组患者的中医证候积分分别为(3。22±1。58)分和(5。44±1。37)分,均较治疗前明显降低(t值分别为 11。38 和12。90,均 P<0。001);且治疗组中医证候积分明显低于对照组(t=-6。01,P<0。001)。治疗后,治疗组和对照组患者的 SDS积分分别为(27。88±3。34)分和(43。88±5。86)分,均较治疗前明显降低(t值分别为 14。05 和 7。86,均P<0。001);且治疗组SDS积分明显低于对照组(t=-13。42,P<0。001)。治疗后,治疗组和对照组患者的HAMD积分分别为(11。38±3。55)分和(18。56±2。12)分,均较治疗前明显降低(t值分别为 15。64 和 5。74,均P<0。001);且治疗组HAMD积分明显低于对照组(t=-9。84,P<0。001)。治疗后,治疗组和对照组FACT-L总积分及身体状况、社会和家庭状况、情绪状况、功能状况、附加的关注领域积分均较治疗前明显升高(均P<0。001);且治疗组除社会和家庭状况外,FACT-L总积分及其他领域积分均明显高于对照组(均P<0。001)。治疗后,治疗组患者CD3+T细胞和CD4+T细胞的比例较治疗前明显升高(均P<0。05),但CD8+T细胞比例、CD4+/CD8+T细胞与治疗前比较,差异无统计学意义(均P>0。05);对照组CD3+T细胞、CD4+T细胞、CD8+T细胞比例和CD4+/CD8+T细胞与治疗前比较,差异均无统计学意义(均P>0。05);治疗组CD3+T细胞、CD4+T细胞比例较对照组明显升高(t值分别为 2。08 和 2。67,均P<0。05)。结论 舒肝养心扶正法能够改善肺癌术后患者的抑郁状态,减轻临床症状,提高生活质量;舒肝养心扶正法联合正念干预则疗效更优,且能提高患者的免疫功能。
Clinical effect of the combined treatment of Shuganyangxin Fuzheng Method and mindfulness intervention in the treatment of depression after lung cancer surgery
Objective To investigate the clinical efficiency of Shuganyangxin Fuzheng method combined with mindfulness intervention on depression after lung cancer surgery.Methods From May 2018 to March 2019,a total of sixty-four patients with depression after lung cancer surgery were randomly divided into the treatment group and the control group,32 cases in each group.The control group was treated with Chinese medicine by using Shuganyangxin Fuzheng Method,the treatment group was treated with mindfulness intervention based on the treatment for the control group,with a course of 3 months.The clinical efficacy and the changes of TCM syndrome scores,Zung Depression Self-Assessment(SDS)scores,Hamilton Depression Scale(HAMD)scores,Function Assessment to Cancer Therapy-Lung(FACT-L)scores,levels of T lymphocyte subsets(CD3+、CD4+、CD8+)were observed.Results The overall clinical effective rates were 93.8%(30/32)in the treatment group and 75.0%(24/32)in the control group,and the clinical efficacy of the treatment group was better than that of the control group(χ2=13.55,P=0.001).After treatment,the TCM syndrome scores of the treatment group and the control group were(3.22±1.58)and(5.44±1.37)points,which were significantly lower than before treatment(t=11.38,t=12.90,all P<0.001),and the TCM syndrome score of the treatment group was significantly lower than that of the control group(t=-6.01,P<0.001).After treatment,the SDS scores of the treatment group and the control group were(27.88±3.34)and(43.88±5.86)points,which were significantly lower than before treatment(t=14.05,t=7.86,all P<0.001),and the SDS score of the treatment group was significantly lower than that of the control group(t=-13.42,P<0.001).After treatment,the HAMD scores of the treatment group and the control group were(11.38±3.55)and(18.56±2.12)points,which were significantly lower than before treatment(t=15.64,t=5.74,all P<0.001),and the HAMD score of the treatment group was significantly lower than that of the control group(t=-9.84,P<0.001).After treatment,the total FACT-L scores and scores for physical condition,social and family status,emotional status,functional status,and additional areas of concern in the treatment group and control group were significantly increased compared to before treatment(all P<0.001).The treatment group had significantly higher FACT-L total scores and scores in other areas,except for social and family status,compared to the control group(all P<0.001).After treatment,the proportion of CD3+T cells and CD4+T cells in the treatment group increased significantly compared to before treatment(all P<0.05),but there was no statistically significant difference in the proportion of CD8+T cells and CD4+/CD8+T cells compared to before treatment(all P>0.05).There was no statistically significant difference in the proportion of CD3+T cells,CD4+T cells,CD8+T cells,and CD4+/CD8+T cells in the control group(all P>0.05).The proportion of CD3+T cells and CD4+T cells in the treatment group was significantly higher than that in the control group(t=2.08,t=2.67,all P<0.05).Conclusions Shuganyangxin Fuzheng method can effectively relieve depression of patients after lung cancer surgery,alleviate the clinical symptoms,and improve the quality of life.The combined treatment with mindfulness intervention shows even better efficacy and can further improve patients'immune function.

Lung neoplasmsDepressionShuganyangxin Fuzheng MethodMindfulness interventionClinical effect

秦若琰、沈丽萍、姜怡、杨晓风、陈晓云、刘苓霜

展开 >

上海中医药大学附属龙华医院肿瘤科,上海 200032

上海中医药大学附属龙华医院风湿免疫科,上海 200032

肺肿瘤:抑郁 舒肝养心扶正法 正念干预 临床疗效

上海市中医肿瘤临床医学研究中心国家中医药管理局高水平中医药重点学科建设项目上海市卫生健康委员会科研项目

21MC1930500ZYYZDXK-202306320214Y0375

2024

中国肿瘤临床与康复
中国癌症研究基金会

中国肿瘤临床与康复

影响因子:0.887
ISSN:1005-8664
年,卷(期):2024.31(8)